We used Kaplan-Meier 2-year survival analysis on CAST registry patients to estimate prognostic power of VPC frequency (≥10/hr), presence of nonsustained ventricular tachycardia (NSVT), left ventricular ejection fraction, and presence of diabetes. We also used meta-analysis of reports in the literature to estimate prognostic power of signal-averaged electrocardiogram (SAECG) and electrophysiological tests (EPS) as well as VPCs, NSVT, and LVEF. Combined results from CAST analysis and literature meta-analysis yielded sensitivity and specificity for VPCs, NSVT, SAECG, LVEF, Diabetes, and EPS. The overall 2 year event rate for life-threatening arrhythmias or death was 7.88% for 51,144 cases in the combined CAST and literature data. After segmenting the population 21.3% were diabetic with a predicted 2 yr event rate of 13.5% and 78.7% were nondiabetic event rate of 6.4%. We defined low risk as <10% and high risk as ≥30%. Otherwise predicted event rate was classified as "unstratified." When all possible combination of noninvasive tests were applied, a prominent difference in the proportions of cases at risk between the diabetics and nondiabetics was revealed. When the unstratified cases were subsequently tested with EPS, the difference between the two groups was even more marked.
|Original language||English (US)|
|Number of pages||5|
|Journal||Journal of Electrocardiology|
|State||Published - 2003|
Bibliographical noteFunding Information:
This work received no outside support. The Cardiac Arrhythmia Suppression Trial was supported by the National Heart, Lung, and Blood Institute, National Institutes of Health.
Copyright 2017 Elsevier B.V., All rights reserved.